The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study.

Bayliss LE, Culliford D, Monk AP, Glyn-Jones S, Prieto-Alhambra D, Judge A, Cooper C, Carr AJ, Arden NK, Beard DJ, Price AJ. · 2017

Read The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study. by Bayliss LE, Culliford D, Monk AP, Glyn-Jones S, Prieto-Alhambra D, Judge A, Cooper C, Carr AJ, Arden NK, Beard DJ, Price AJ. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5522532.txt.

Introduction

Bayliss and co-authors report a cohort study in The Lancet on joint replacement revision risk. Hip and knee replacements relieve end-stage arthritis well. Patients still need honest odds on needing a second operation. Those odds hinge on age at the first surgery. The team mined UK primary care records for over 117,000 patients.

Implants lasted 20 years in about 85 to 90 percent of cases, they report. Patients over 70 faced only about a 5 percent lifetime revision risk. Men in their early 50s faced up to 35 percent. Women of that age ran notably lower risk. The figures challenge the drift toward ever-younger surgery.

Catalog record

CREATORBayliss LE, Culliford D, Monk AP, Glyn-Jones S, Prieto-Alhambra D, Judge A, Cooper C, Carr AJ, Arden NK, Beard DJ, Price AJ.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5522532

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study By Lee E Bayliss, David Culliford, A Paul Monk, Sion Glyn-Jones, Daniel Prieto-Alhambra, Andrew Judge, Cyrus Cooper, Andrew J Carr, Nigel K Arden, David J Beard, Andrew J Price Published in: Lancet (London, England) DOI: 10.1016/S0140-6736(17)30059-4 ABSTRACT Summary Background Total joint replacements for end-stage osteoarthritis of the hip and knee are cost-effective and demonstrate significant clinical improvement. However, robust population based lifetime-risk data for implant revision are not available to aid patient decision making, which is a particular problem in young patient groups deciding on best-timing for surgery. Methods We did implant survival analysis on all patients within the Clinical Practice Research Datalink who had undergone total hip replacement or total knee replacement. These data were adjusted for all-cause mortality with data from the Office for National Statistics and used to generate lifetime risks of revision surgery based on increasing age at the time of primary surgery. Findings We identified 63 158 patients who had undergone total hip replacement and 54 276 who had total knee replacement between Jan 1, 1991, and Aug 10, 2011, and followed up these patients to a maximum of 20 years. For total hip replacement, 10-year implant survival rate was 95·6% (95% CI 95·3–95·9) and 20-year rate was 85·0% (83·2–86·6). For total knee replacement, 10-year implant survival rate was 96·1% (95·8–96·4), and 20-year implant survival rate was 89·7% (87·5–91·5). The lifetime risk of requiring revision surgery in patients who had total hip replacement or total knee replacement over the age of 70 years was about 5% with no difference between sexes. For those who had surgery younger than 70 years, however, the lifetime risk of revision increased for younger patients, up to 35% (95% CI 30·9–39·1) for men in their early 50s, with large differences seen between male and female patients (15% lower for women in same age group). The median time to revision for patients who had surgery younger than age 60 was 4·4 years. Interpretation Our study used novel methodology to investigate and offer new insight into the importance of young age and risk of revision after total hip or knee replacement. Our evidence challenges the increasing trend for more total hip replacements and total knee replacements to be done in the younger patient group, and these data should be offered to patients as part of the shared decision making process. Funding Oxford Musculoskeletal Biomedical Research Unit, National Institute for Health Research. INTRODUCTION Hip and knee replacements have been routinely done for the treatment of end-stage arthritis over the past 40 years;1, 2 76 000 total hip replacements and 82 000 total knee replacements were done in 2014 in the UK alone,3 with the greatest increase in the number of total knee replacements in recent years. The outcomes of joint replacements are determined in several different ways, including mortality4, 5 and morbidity rates after surgery, functional outcome and satisfaction recorded as patient-reported outcome scores,6 and by rates of failure of the implant leading to revision surgery.3, 7 Total hip replacement and total knee replacement have demonstrated improved function,8 reduced pain, and improved quality of life9 for patients, and are cost-effective.9 Predictions are that in the next 10–20 years primary joint replacement rates will substantially increase, not only as a consequence of an ageing population, but also because of increasing use in patients younger than age 60 years,10 who currently represent 15% of the entire population undergoing surgery, but might increase in the future.11 This rise in the number of patients younger than 60 years undergoing surgery is a concern because joint registries reveal that 10-year revision rates in this group are higher than for older age groups.3 For all patients, the decision to have surgery is largely based on the balance between potential risk and benefit. The James Lind Alliance Priority Setting Partnership, a public–patient involvement group, has established that the relation between timing of joint replacement and best outcome is one of the most significant concerns for patients with osteoarthritis. This is of particular importance in determining optimum timing for surgery in younger patients, where they can be expected to potentially outlive their primary replacement. Therefore, the length of time a joint replacement will last (before requiring revision) becomes a major factor in deciding whether to proceed with surgery. The most widely used and quoted data for risk of revision come from joint registry reports, but are often limited to 10 years of follow-up.3, 7, 12 Other studies with longer patient follow-up (greater than 20 years) are frequently restricted to specific prostheses or small populations, without specific focus on the results from patients younger than 60 years at implantation.13, 14 Therefore, for these patients, information about implant revision rates tends to be restricted to 10 years, and although worse than those seen for patients older than 60,3, 9, 15 might not truly reflect the risk of revision over the longer timeframe. The decision making process for younger patients is hence not fully informed, and could lead to inappropriate election to undergo joint replacement.15, 16 Research in contextEvidence before this studyWe searched Medline, Embase, and the Cochrane Library up to Nov 2015 for all studies investigating lifetime risk of revision in total hip and total knee replacement or arthroplasty. Whilst publications were identified for lifetime risk of undergoing primary joint replacement of the hip or knee, no such studies were found for lifetime risk of revision surgery. Review of National Joint Registries reports (England & Wales, Australia, New Zealand, Sweden, Norway, Denmark) revealed publication of annual survival incidences but not lifetime risk predictions.Added value of this studyThis study proposes the use of lifetime revision risk predictions, based on a large dataset, as a useful and novel tool for both clinicians and patients. Although data are available that describe the lifetime risk of need for primary joint replacement, data have not been published for revision risk following primary procedure. Before this study, revision rates have been quoted as survival incidences (usually at 10 years) however the context of a 10-year revision risk is very different for young patients compared to those of greater age, for whom 10 years could represent the majority of their life-expectancy. This study allows patients to understand the risk in the context of their predicted life-expectancy, and as such, better inform their decision to undergo joint replacement surgery.Implications of all the available evidencePrevious study data, increasingly based upon national registers, showed that young patients are at a higher risk of revision than are older patients; this study expands upon this problem to better highlight how much greater this risk is over a patient's lifetime and to put this into a statistic that is easier to explain to patients considering surgery. The number of younger patients undergoing joint replacement surgery is increasing and it is crucial that their decision to undergo surgery is based on best available, personalised evidence. There is a clear need for more representative long-term data that could be used to inform patients of the risk of revision surgery. One approach that has not previously been used comes from combining data from the Clinical

Read the complete text